Insider Transactions in Q1 2023 at Intercept Pharmaceuticals, Inc. (ICPT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
909
-1.28%
|
$12,726
$14.19 P/Share
|
|
Mar 14
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-1.49%
|
$18,690
$15.79 P/Share
|
|
Feb 14
2023
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-0.88%
|
$8,106
$21.21 P/Share
|
|
Feb 01
2023
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
918
-1.54%
|
$16,524
$18.76 P/Share
|
|
Jan 27
2023
|
Jared Freedberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
12,200
+16.97%
|
-
|
|
Jan 27
2023
|
Linda M Richardson EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,200
+21.83%
|
-
|
|
Jan 27
2023
|
Andrew Saik EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,700
+17.15%
|
-
|
|
Jan 27
2023
|
Rocco Venezia Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,800
+27.8%
|
-
|
|
Jan 27
2023
|
M Michelle Berrey President, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
14,700
+14.91%
|
-
|
|
Jan 27
2023
|
Jerome Benedict Durso CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,400
+24.58%
|
-
|
|
Jan 27
2023
|
David A Ford Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,800
+21.19%
|
-
|